Oncogene mutation hijacks splicing process to promote growth and survival

Median survival after GBM diagnosis is just 15 months with standard-of care radiation and chemotherapy. Without treatment, it is less than five months. The scientists were particularly interested in whether the EGFRvIII mutation induced alternative …
See all stories on this topic »